Completed PHASE1 INTERVENTIONAL 4-arm NCT05276206

Application of Transversus Abdominus Plain Block, Local Subcutaneous Injection and IV Nalbuphine

Comparative Study Between Transversus Abdominus Plain Block, Local Subcutaneous Injection in the Wound, and Intravenous Nalbuphine in Decreasing Postoperative Pain in Cesarean Section

Sponsor: Egymedicalpedia

Conditions Cesarean Section Pain Post Operative Pain

Interventions NSAID , NALUFIN , local anesthetic andTAP Block

Updated 5 times since 2022 Last updated: Jul 6, 2023 Started: Mar 7, 2022 Primary completion: Mar 20, 2022 Completion: Apr 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Cesarean Section Pain and Post Operative Pain, this trial is completed. The trial is conducted by Egymedicalpedia and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Aug 2023 — Jul 2024 [monthly]

Completed PHASE1
May 2022 — Aug 2023 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Apr 2022 — May 2022 [monthly]

Recruiting PHASE1

First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Egymedicalpedia

Data source: Egymedicalpedia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt